바이오벤투스 주식회사
US ˙ NasdaqGS ˙ US09075A1088

SecurityBVS / Bioventus Inc.
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership103,528 shares
Latest Disclosed Value $ 945,211
Marshall Wace, Llp reports 64.16% decrease in ownership of BVS / Bioventus Inc.

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 103,528 shares of Bioventus Inc. (US:BVS) valued at $945,211 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 288,900 shares of Bioventus Inc.. This represents a change in shares of -64.16% during the quarter. The current value of the position is $935,893 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BIOVENTUS - A COMMON STOCK 09075A108 103,528 -185,372 -64.16 945 -56.03 0.0009
2026-02-13 2025-12-31 13F BIOVENTUS - A COMMON STOCK 09075A108 288,900 1,281 0.45 2,149 11.69 0.0020
2025-11-13 2025-09-30 13F BIOVENTUS - A COMMON STOCK 09075A108 287,619 75,924 35.86 1,924 37.33 0.0020
2025-08-13 2025-06-30 13F BIOVENTUS - A COMMON STOCK 09075A108 211,695 51,951 32.52 1,401 -4.11 0.0016
2025-05-15 2025-03-31 13F BIOVENTUS - A COMMON STOCK 09075A108 159,744 86,321 117.57 1,462 89.74 0.0019
2025-02-13 2024-12-31 13F BIOVENTUS - A COMMON STOCK 09075A108 73,423 -307,404 -80.72 771 -83.08 0.0009
2024-11-14 2024-09-30 13F BIOVENTUS - A COMMON STOCK 09075A108 380,827 48,536 14.61 4,551 138.22 0.0055
2024-08-14 2024-06-30 13F BIOVENTUS - A COMMON STOCK 09075A108 332,291 91,843 38.20 1,911 52.80 0.0026
2024-05-15 2024-03-31 13F BIOVENTUS - A COMMON STOCK 09075A108 240,448 49,813 26.13 1,250 24.50 0.0019
2024-02-14 2023-12-31 13F BIOVENTUS - A COMMON STOCK 09075A108 190,635 -74,314 -28.05 1,005 14.87 0.0017
2023-11-14 2023-09-30 13F BIOVENTUS - A COMMON STOCK 09075A108 264,949 194,178 274.38 874 328.43 0.0018
2023-08-14 2023-06-30 13F BIOVENTUS - A COMMON STOCK 09075A108 70,771 70,771 205 0.0004
2022-08-15 2022-06-30 13F BIOVENTUS - A COMMON STOCK 09075A108 0 -10,440 -100.00 0 -100.00
2022-05-16 2022-03-31 13F BIOVENTUS - A COMMON STOCK 09075A108 10,440 -164,751 -94.04 147 -94.21 0.0003
2022-02-14 2021-12-31 13F BIOVENTUS - A COMMON STOCK 09075A108 175,191 175,191 2,539 0.0047
2021-08-13 2021-06-30 13F BIOVENTUS - A COMMON STOCK 09075A108 0 -20,756 -100.00 0 -100.00
2021-05-17 2021-03-31 13F BIOVENTUS - A COMMON STOCK 09075A108 20,756 20,756 317 0.0015
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.